Drugs / ActHIB® (Haemophilus influenzae type b Conjugate Vaccine)
last change Nov 2009 re-read 2 minutes ago

ActHIB® (Haemophilus influenzae type b Conjugate Vaccine)

also known as Hib

Vaccine

Investigated by
Novartis Vaccines

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00474526 Mar 2007 → Sep 2008 meningococcal meningitis Novartis Vaccines Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ActHIB (Haemophilus influenzae type b Conjugate Vaccine) “ActHIB® (Haemophilus influenzae type b Conjugate Vaccine)” NCT00474526
Known as Hib ClinicalTrials.gov intervention name — accepted as the source's own label NCT00474526
Modality Vaccine “ActHIB® (Haemophilus influenzae type b Conjugate Vaccine)” NCT00474526